Cardlytics, Inc (CDLX) AI Stock Analysis

Cardlytics, Inc. operates an advertising platform across the United States and the United Kingdom. Its flagship Cardlytics platform connects marketers with customers using a native bank advertising channel integrated into financial institution partners' digital touchpoints, including mobile applications, online platforms, email, and real-time notifications. The company also provides the Bridg customer data platform, which leverages point-of-sale data to offer analytics and targeted loyalty marketing capabilities. Founded in 2008 and based in Atlanta, Georgia, Cardlytics utilizes financial transaction data to deliver targeted marketing and measure marketing return on investment.

Cardlytics grew annual revenue from $267.1M in FY2021 to a peak of $309.2M in FY2023, before contracting to $278.3M in FY2024 and $233.3M in FY2025. Gross margin expanded from 38.7% in FY2021 to 45.0% in FY2025. However, operating margins have remained negative, landing at -20.2% in FY2025 alongside a net loss of -$103.5M. In the latest quarter ended June 30, 2026, revenue decreased 36.5% year-over-year, and earnings declined 56.7% year-over-year. TTM revenue reached $190.0M with a profit margin of -52.8% and EPS of -$18.99.

As of June 30, 2026, Cardlytics held $28.0M in cash and short-term investments against $189.9M in total debt, resulting in net debt of $161.8M. The company maintains a current ratio of 1.62, while total assets were $234.8M and shareholders' equity stood at -$16.0M. Operating cash flow improved to $9.3M in FY2025 compared to -$8.8M in FY2024, but free cash flow remained negative at -$6.5M after capital expenditures of $15.8M. Over the past five years, Cardlytics' share count increased by 72.5%.

Cardlytics carries a market capitalization of $12.0M and an enterprise value of $182.4M. Its forward P/E ratio is 36.5x, compared to the median of 14.1x for its US-listed Communication Services peers. The stock trades at a price-to-sales multiple of 0.1x, below the peer group median of 0.8x, and an EV-to-revenue multiple of 1.0x. Over the past year, CDLX shares declined 89.8%, while the S&P 500 (SPY) gained 16.8%. Over five years, the stock fell 99.8% against an 83.0% increase for the index.

Cardlytics is covered by 4 analysts, with 3 issuing Hold ratings and 1 recommending Sell. The mean price target is $6.00, representing a 195.6% premium over the last close of $2.03. Consensus projections estimate FY2026 revenue of $148.7M and an EPS of -$2.31. For FY2027, 2 analysts project revenue of $160.9M and an EPS of -$3.29. The company has beat EPS estimates in 2 of the trailing 4 quarters, and its next earnings release is scheduled for November 4, 2026.

This page is an AI-written research summary of Cardlytics, Inc (CDLX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CDLX income statement, CDLX balance sheet, CDLX key metrics, CDLX analyst forecast, CDLX chart. See the CDLX stock overview for the latest quote and news.